News & Insights Search

The European Medicines Agency (EMA) has published a document detailing its methodology for monitoring potential vulnerabilities in the medicine supply chains. The agency said its new framework is intended to prevent potential shortages of drugs considered especially important on the Union List of Critical Medicines (ULCM).

The US Food and Drug Administration (FDA) has issued a draft guidance to industry that specifies where sponsors should submit 'cross-center” master files (MFs) that are referenced and intended to support more than one regulatory submission. The guidance applies to combination products and non-combination products.

The World Health Organization (WHO) issued an alert on Monday identifying oral cough syrups manufactured in India that contain diethylene glycol (DEG), a substance typically used as an industrial solvent and in antifreeze. According to the BBC, at least 20 children in India have died after ingesting these cough syrups.

The United States tends to source finished dosage forms (FDFs) of antibiotic products from many different countries while relying on China for a majority of imported active pharmaceutical ingredients (APIs), according to recent research published in JAMA Health Forum.

As a part of the effort, IPC created a short film on PvPI, a pharmacovigilance comic published in multiple vernacular languages to enhance public awareness, and a new online reporting platform designed for easy access through a QR code.

Supply chain experts reported that most distributors were able to meet the enhanced tracing requirements outlined in the Drug Supply Chain Security Act (DSCSA) by the 27 August deadline. After this date, only serialized data can be exchanged for every transaction and wholesalers must have the systems in place to handle electronic data on each product transfer.

Negotiations between the UK government and the pharmaceutical industry have ended without an agreement on changes to the medicines payment scheme.

Malaysia's Medical Device Authority (MDA) and Singapore's Health Sciences Authority (HSA) unveiled a pilot program that could accelerate access to Class B, C, and D medical devices. The pilot program begins on 1 September and runs through 28 February.

Most pharmaceutical manufacturing facilities in the US are situated in regions prone to hurricanes, wildfires, and other natural disasters, placing the supply chain in significant jeopardy, according to a research letter published in JAMA.

On 13 August, President Donald Trump issued an executive order directing the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services (HHS) to identify 26 drugs that are essential for public health. The executive order also mandates that a six-month supply of active pharmaceutical ingredients (APIs) necessary for manufacturing these drugs be stockpiled. ASPR has 30 days to compile this list of essential drugs.

A recent report from the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) highlights significant weaknesses in the global pharmaceutical supply chain that have resulted in patients – especially children – consuming medicines contaminated with harmful levels of toxic chemicals, such as diethylene glycol (DEG) and ethylene glycol (EG).

The European Commission has determined that there are no viable alternatives to titanium dioxide (TiO2) as an excipient in many pharmaceutical products. They also identified a risk of shortages if a ban were implemented, which could negatively impact patients due to the large number of medicinal products affected.

Supply chain experts said that most manufacturers successfully implemented the enhanced tracing requirements outlined in the Drug Supply Chain Security Act (DSCSA) by the 27 May deadline without significant issues. In addition, they said that wholesalers are optimistic about meeting the upcoming deadline of 27 August, which marks the end of the exemption period.

PDG said selection of the Korean Pharmacopoeia was a consensus decision that 'reflects the quality of the Korean Pharmacopoeia's application and its alignment with the PDG's mission to promote global harmonization of pharmacopeial standards.”

The survey also uncovered problems as respondents 'highlighted challenges such as the regulatory burden, access to finance and regulatory fees, calling for regulatory simplification and streamlining, access to funding and enhanced advice and support,” EMA noted.

'With this change, the Brazilian market is expected to become more attractive for conducting clinical trials,” wrote legal analysts wrote in Lexology.

Two pharmaceutical industry representatives told the House Energy and Commerce Health subcommittee on Wednesday that offering tax credits and long-term purchasing commitments to domestic pharmaceutical manufacturers would enhance the US manufacturing base.

The International Council for Harmonisation (ICH) has recently released two draft guidelines for public consultation. One draft guideline focuses on assessing new drugs for pregnant populations in clinical trials, while the other provides updates to the information requested in the quality section of the Common Technical Document (CTD).

India's Department of Pharmaceuticals (DoP) is planning to study the country's pharmaceutical and medical device supply chains to identify regulatory bottlenecks and find ways to enhance the reliability and efficiency of logistics.

Medicine and medical device industry groups have told the EU how they would like the region to respond to tariffs the Trump administration has imposed on imports into the US. The talks took place before 9 April, when US President Donald Trump paused the higher tariffs on the EU for 90 days.